Published in Biochemistry on July 01, 1968
A rapid method for the preparation of relatively pure metabolically competent synaptosomes from rat brain. Biochem J (1978) 1.64
Effect of diphenylhydantoin on synaptosome sodium-potassium-ATPase. J Clin Invest (1968) 1.37
Protein synthesis in synaptosomal fractions. Ultrastructural radioautographic study. J Cell Biol (1972) 1.01
Can mitochondria and synaptosomes of guinea-pig brain synthesize phospholipids? Biochem J (1972) 0.98
Morphological and biochemical changes in rat synaptosome fractions during neonatal development. J Cell Biol (1971) 0.93
Phenethylamines in brain and liver of rats with experimentally induced phenylketonuria-like characteristics. Biochem J (1973) 0.86
Catecholamines and the hydroxylation of tyrosine in synaptosomes isolated from rat brain. Proc Natl Acad Sci U S A (1971) 0.84
Studies on memory: distribution of peptidyl-puromycin in subcellular fractions of mouse brain. Proc Natl Acad Sci U S A (1971) 0.84
Protein synthesis by synaptosomes from rat brain. Contribution by the intraterminal mitochondria. Biochem J (1974) 0.83
Increasing our understanding of human cognition through the study of Fragile X Syndrome. Dev Neurobiol (2013) 0.82
Lasting biological effects of early environmental influences. VII. Metabolism of adenosine in mice exposed to early environmental stress. J Exp Med (1972) 0.78
Properties of catechol O-methyltransferases from brain and liver of rat and human. Biochem J (1975) 0.78
Qualitative and quantitative morphological changes in subcellular fractions from mouse cerebral cortex during postnatal development. J Cell Biol (1973) 0.76
Studies on valinomycin inhibition of synaptosome-fraction protein synthesis. Biochem J (1981) 0.75
Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain (1995) 2.99
Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis. N Engl J Med (1992) 2.86
Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology (2005) 2.72
Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors. Science (1974) 2.69
Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial design. Neurology (2011) 2.28
Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial. Neurology (2004) 2.26
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. Neurology (2008) 2.17
A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis. Neurology (2003) 2.10
Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology (2001) 2.01
Effects of phagocytosis by rabbit granulocytes on macromolecular synthesis and degradation in different species of bacteria. J Bacteriol (1973) 1.87
A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer disease. Ann Neurol (1981) 1.75
The lipid composition of purified bovine brain myelin. J Neurochem (1966) 1.62
Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination. Neuron (1996) 1.58
Frontal-lobe mediated behavioral dysfunction in amyotrophic lateral sclerosis. Eur J Neurol (2009) 1.54
Depressed interferon gamma production and monocyte HLA-DR expression after severe injury. Arch Surg (1988) 1.53
Acetylcholine receptor antibodies in myasthenia gravis. N Engl J Med (1975) 1.52
Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease. J Neurosci (2001) 1.52
Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Arch Neurol (1993) 1.51
Amyotrophic lateral sclerosis patient antibodies label Ca2+ channel alpha 1 subunit. Ann Neurol (1994) 1.50
Long-term neuromuscular dysfunction produced by passive transfer of amyotrophic lateral sclerosis immunoglobulins. Neurology (1992) 1.49
Detection of intraabdominal abscess by serum lysozyme estimation. Surgery (1994) 1.43
Carrier detection in Duchenne muscular dystrophy. N Engl J Med (1976) 1.42
The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Ann Neurol (1994) 1.40
The Lambert-Eaton syndrome. Hosp Pract (Off Ed) (1992) 1.39
Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins. Proc Natl Acad Sci U S A (1977) 1.39
Effect of diphenylhydantoin on synaptosome sodium-potassium-ATPase. J Clin Invest (1968) 1.37
IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. Arch Neurol (1990) 1.35
A novel N18TG2 x mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin. J Neurosci (1992) 1.30
Prognosis of amyotrophic lateral sclerosis and the effect of referral selection. J Neurol Sci (1995) 1.29
Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population. J Neurol Neurosurg Psychiatry (2006) 1.24
Reduced Nurr1 expression increases the vulnerability of mesencephalic dopamine neurons to MPTP-induced injury. J Neurochem (1999) 1.21
Interaction of myasthenic serum globulin with the acetylcholine receptor. Biochim Biophys Acta (1975) 1.21
Phospholipid metabolism by phagocytic cells. VII. The degradation and utilization of phospholipids of various microbial species by rabbit granulocytes. Biochim Biophys Acta (1972) 1.21
Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden. Neurology (2004) 1.15
Persistence of regulation of macromolecular synthesis by Escherichia coli during killing by disrupted rabbit granulocytes. Infect Immun (1974) 1.14
Protein kinase activity in erythrocyte ghosts of patients with myotonic muscular dystrophy. Proc Natl Acad Sci U S A (1973) 1.12
Parvalbumin overexpression alters immune-mediated increases in intracellular calcium, and delays disease onset in a transgenic model of familial amyotrophic lateral sclerosis. J Neurochem (2001) 1.12
Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis. Ann Neurol (1996) 1.12
Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (1996) 1.11
The effects of the morphine analogue levorphanol on leukocytes. Metabolic effects at rest and during phagocytosis. J Clin Invest (1971) 1.10
Protective role of heme oxygenase-1 in oxidative stress-induced neuronal injury. J Neurosci Res (1999) 1.09
Selective agenesis of mesencephalic dopaminergic neurons in Nurr1-deficient mice. Exp Neurol (1999) 1.09
Role of potassium channels in amyloid-induced cell death. J Neurochem (1998) 1.08
Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis. Am J Pathol (1992) 1.08
Erythrocyte protein phosphorylation. J Biol Chem (1973) 1.08
ALS disease onset may occur later in patients with pre-morbid diabetes mellitus. Eur J Neurol (2010) 1.07
Cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line. Proc Natl Acad Sci U S A (1994) 1.07
Experimental destruction of substantia nigra initiated by Parkinson disease immunoglobulins. Arch Neurol (1998) 1.06
Ca2+ current and charge movement in adult single human skeletal muscle fibres. J Physiol (1992) 1.05
Scanning electron microscopy studies in muscular dystrophy. Arch Neurol (1976) 1.05
Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice. Neurosci Lett (2000) 1.04
Effects of normal and myasthenic serum factors on innervated and chronically denervated mammalian muscles. Ann N Y Acad Sci (1976) 1.04
A rating scale for amyotrophic lateral sclerosis: description and preliminary experience. Ann Neurol (1987) 1.04
Calcium current and charge movement of mammalian muscle: action of amyotrophic lateral sclerosis immunoglobulins. J Physiol (1991) 1.04
A comparative electron spin resonance study of the erythrocyte membrane in myotonic muscular dystrophy. Biochemistry (1974) 1.02
Electron spin resonance studies of erythrocytes from patients with myotonic muscular dystrophy. Proc Natl Acad Sci U S A (1974) 1.02
Attenuation of the neurotoxic effect of A beta amyloid peptide by apolipoprotein E. Biochem Biophys Res Commun (1994) 1.01
Biochemical studies of synapses in vitro. II. Potassium transport. Biochemistry (1969) 1.00
Wheelchair use by patients with amyotrophic lateral sclerosis: a survey of user characteristics and selection preferences. Arch Phys Med Rehabil (2001) 1.00
The value of database controls in pilot or futility studies in ALS. Neurology (2006) 0.99
Brain polysomes: response to environmental stimulation. Science (1967) 0.99
Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis. Ann Neurol (1998) 0.99
Decremental motor responses to repetitive nerve stimulation in ALS. Muscle Nerve (1994) 0.99
Cholinergic sites in skeletal muscle. I. Denervation effects. Biochemistry (1976) 0.98
Cell death induced by beta-amyloid 1-40 in MES 23.5 hybrid clone: the role of nitric oxide and NMDA-gated channel activation leading to apoptosis. Brain Res (1995) 0.98
Myotonic muscular dystrophy: altered calcium transport in erythrocytes. Science (1978) 0.98
A generalized disorder of nervous system, skeletal muscle and heart resembling Refsum's disease and Hurler's syndrome. I. Clinical, pathologic and biochemical characteristics. Am J Med (1967) 0.98
SEPT9 gene sequencing analysis reveals recurrent mutations in hereditary neuralgic amyotrophy. Neurology (2009) 0.98
Purification and kinetic properties of brain orotidine 5'-phosphate decarboxylase. J Biol Chem (1968) 0.97
HFE mutations are not strongly associated with sporadic ALS. Neurology (2004) 0.97
Serum acetylcholine-receptor antibodies in myasthenia gravis. Ann N Y Acad Sci (1976) 0.97
Interferon-gamma treatment increases HLA-DR expression on monocytes in severely injured patients. Clin Exp Immunol (1989) 0.96
Adult-onset combined methylmalonic aciduria and homocystinuria (cblC). Neurology (2001) 0.96
Decreased mRNA expression of tight junction proteins in lumbar spinal cords of patients with ALS. Neurology (2009) 0.95
Hippocampal cholinergic neurostimulating peptides (HCNP). Prog Neurobiol (2000) 0.95
Muscle membrane protein kinase in myotonic muscular dystrophy. Nature (1974) 0.94
Experimental autoimmune motoneuron disease. Ann Neurol (1989) 0.94
Immunoglobulins from amyotrophic lateral sclerosis patients enhance spontaneous transmitter release from motor-nerve terminals. Proc Natl Acad Sci U S A (1988) 0.94
Kinetic studies on rat liver carbamyl phosphate synthetase. J Biol Chem (1968) 0.94
Spin label study of erythrocyte membrane fluidity in myotonic and Duchenne muscular dystrophy and congenital myotonia. Nature (1976) 0.94
Reduction of naturally occurring motoneuron death in vivo by a target-derived neurotrophic factor. Science (1988) 0.93
Acetylcholine receptor in normal and denervated slow and fast muscle. Biochemistry (1974) 0.93
Amyotrophic lateral sclerosis. Associated clinical disorders and immunological evaluations. Arch Neurol (1986) 0.93
Isolation and characterization of the surface membranes of fast and slow mammalian skeletal muscle. Biochim Biophys Acta (1977) 0.91
Intracellular calcium parallels motoneuron degeneration in SOD-1 mutant mice. J Neuropathol Exp Neurol (1998) 0.91
Regulation of acetylcholine receptor by cyclic AMP. J Biol Chem (1980) 0.90
The effect of tumor necrosis factor-alpha and interferon-gamma on neutrophil function. J Surg Res (1989) 0.90
Phospholipase activity associated with serum albumin. Biochim Biophys Acta (1973) 0.90
Stereotaxic injection of IgG from patients with Alzheimer disease initiates injury of cholinergic neurons of the basal forebrain. Arch Neurol (2000) 0.90
Antioxidant property of pramipexole independent of dopamine receptor activation in neuroprotection. J Neural Transm (Vienna) (2000) 0.90
Synthesis de novo of purines in slices of rat brain and liver. J Neurochem (1970) 0.89
Phosphorylation of myelin basic protein. J Biol Chem (1974) 0.89
Antibodies from patients with Parkinson's disease react with protein modified by dopamine oxidation. J Neurosci Res (1998) 0.89
Molecular approaches to amyotrophic lateral sclerosis. Annu Rev Med (1995) 0.88
Inhibition of brain protein synthesis: an approach to the biochemical basis of neurological dysfunction in the amino-acidurias. Trans N Y Acad Sci (1966) 0.88
IgG from amyotrophic lateral sclerosis affects tubular calcium channels of skeletal muscle. Am J Physiol (1991) 0.88
Phosphorylation of component a of the human erythrocyte membrane in myotonic muscular dystrophy. J Membr Biol (1975) 0.88
Biochemical studies of synapses in vitro. 3. Ionic activation of protein synthesis. J Biol Chem (1969) 0.88
Organization of acetylcholine receptor clusters in cultured rat myotubes is calcium dependent. J Cell Biol (1984) 0.87
Macromolecular characterization of muscle membranes. I. Proteins and sialic acid of normal and denervated muscle. J Biol Chem (1973) 0.87